Short Interest
Shares sold short and not yet bought back, reported to FINRA twice a month by every member firm. This is a standing position, not daily trading — the two get confused constantly and mean very different things.
The number that frames everything else
5.0 days is the median time it would take to buy back the short position in a typical listed security at its own recent trading volume. Anything in low single digits is ordinary. The names at the top of this list would need weeks of their entire daily volume, which is the condition people are describing when they say a short is crowded.
| Ticker | Days to cover | Shares short | Change | Daily volume | Venue |
|---|---|---|---|---|---|
| IPSC Century Therapeutics, Inc. | 29.5M | +0.5% | 418,031 | SC | |
| IKT Inhibikase Therapeutics, Inc. | 19.5M | -0.9% | 411,228 | SC | |
| DMAC DiaMedica Therapeutics Inc. | 5.4M | +0.7% | 114,369 | SC | |
| AVIR Atea Pharmaceuticals, Inc. | 7.7M | -0.1% | 186,207 | NNM | |
| IMO Imperial Oil Limited | 19.6M | -2.3% | 496,640 | AMEX | |
| XRXDW Xerox Holdings Corporation War | 5.6M | -0.2% | 155,865 | NNM | |
| TLSI TriSalus Life Sciences, Inc. C | 3.7M | -2.6% | 102,902 | NNM | |
| CIA Citizens, Inc. | 4.3M | -0.6% | 121,756 | NYSE | |
| GALT Galectin Therapeutics Inc. | 9.1M | +0.8% | 272,112 | SC | |
| LCTX Lineage Cell Therapeutics, Inc. | 29.0M | +2.3% | 876,205 | AMEX | |
| CBUS Cibus, Inc. Class A Common Sto | 3.5M | +2.5% | 106,207 | SC | |
| FLNA Filana Therapeutics, Inc. Comm | 6.3M | -0.3% | 192,671 | SC | |
| FLWS 1-800-FLOWERS.COM, Inc. | 7.7M | -0.1% | 250,438 | NNM | |
| CRVS Corvus Pharmaceuticals, Inc. | 19.0M | -0.6% | 641,670 | NNM | |
| SRG Seritage Growth Properties Cla | 4.6M | +0.4% | 161,539 | NYSE | |
| HPK HighPeak Energy, Inc. | 9.1M | -1.9% | 318,855 | NNM | |
| OCGN Ocugen, Inc. | 98.3M | -3.4% | 3.5M | SC | |
| HURA TuHURA Biosciences, Inc. | 6.3M | -0.9% | 224,416 | SC | |
| TYRA Tyra Biosciences, Inc. | 9.4M | -2.6% | 347,850 | NNM | |
| IMRX Immuneering Corporation | 14.8M | +2.9% | 547,452 | NNM | |
| LXEO Lexeo Therapeutics, Inc. | 20.5M | +0.0% | 763,910 | NNM | |
| ANL Adlai Nortye Group Ltd. | 4.1M | -4.1% | 153,722 | NNM | |
| DEI Douglas Emmett, Inc. | 29.7M | +3.1% | 1.1M | NYSE | |
| OTTR Otter Tail Corporation | 4.8M | -1.6% | 180,427 | NNM | |
| CURV Torrid Holdings Inc. | 4.2M | +3.2% | 162,271 | NYSE | |
| SPTX Seaport Therapeutics, Inc. Com | 3.2M | +4.6% | 121,336 | NNM | |
| PRTA Prothena Corporation plc | 8.5M | -0.6% | 341,894 | NNM | |
| SVRA Savara, Inc. | 41.4M | +7.6% | 1.7M | NNM | |
| ORGO Organogenesis Holdings Inc. - Class A | 14.2M | +0.1% | 594,717 | SC | |
| CATX Perspective Therapeutics, Inc. | 23.4M | +1.4% | 987,921 | AMEX | |
| LFCR Lifecore Biomedical, Inc. Comm | 2.4M | +0.3% | 104,477 | NNM | |
| MAIN Main Street Capital Corporation | 9.4M | +0.2% | 408,024 | NYSE | |
| CD Chaince Digital Holdings Inc. | 5.4M | +6.6% | 233,032 | NNM | |
| DDD 3D Systems Corporation | 43.7M | +0.3% | 1.9M | NYSE | |
| SOBO South Bow Corporation | 11.1M | -1.9% | 488,296 | NYSE | |
| BCAX Bicara Therapeutics Inc. Commo | 10.8M | +3.7% | 491,104 | NNM | |
| MMYT MakeMyTrip Limited | 8.1M | -9.5% | 368,914 | NNM | |
| RYTM Rhythm Pharmaceuticals, Inc. | 10.3M | +1.5% | 470,672 | NNM | |
| SKYH Sky Harbour Group Corporation Class A | 3.1M | -5.9% | 149,429 | NYSE | |
| MPT Medical Properties Trust, Inc. | 150.1M | +3.9% | 7.2M | NYSE | |
| IMCR Immunocore Holdings plc | 7.8M | -1.3% | 374,592 | NNM | |
| BBOT BridgeBio Oncology Therapeutic | 6.2M | +6.6% | 298,249 | NNM | |
| TROW T. Rowe Price Group, Inc. | 26.2M | +5.1% | 1.3M | NNM | |
| CNQ Canadian Natural Resources Limited | 113.2M | +96.3% | 5.5M | NYSE | |
| FTS Fortis Inc. | 15.1M | -4.3% | 735,849 | NYSE | |
| AVBP ArriVent BioPharma, Inc. | 8.7M | +5.6% | 425,433 | NNM | |
| CGTX Cognition Therapeutics, Inc. | 7.9M | +10.3% | 386,413 | SC | |
| FIP FTAI Infrastructure Inc. | 19.3M | +0.4% | 952,303 | NNM | |
| BYSI BeyondSpring Inc. Ordinary Sha | 2.3M | -15.5% | 114,458 | SC | |
| CBIO Crescent Biopharma, Inc. | 3.2M | -1.4% | 159,313 | SC | |
| LBRX LB Pharmaceuticals Inc Common | 5.3M | +2.4% | 265,345 | NNM | |
| RNA Atrium Therapeutics, Inc. | 3.4M | -3.7% | 169,372 | NNM | |
| IBTA Ibotta, Inc. Class A | 3.2M | -1.6% | 161,030 | NYSE | |
| TNGX Tango Therapeutics, Inc. | 42.6M | -1.3% | 2.2M | NNM | |
| SNDX Syndax Pharmaceuticals, Inc. | 21.7M | -5.3% | 1.1M | NNM | |
| XRX Xerox Holdings Corporation | 40.5M | +3.5% | 2.1M | NNM | |
| RDNT RadNet, Inc. | 9.9M | +2.6% | 510,678 | NNM | |
| RCI Rogers Communication, Inc. | 18.1M | +6.6% | 930,392 | NYSE | |
| TSHA Taysha Gene Therapies, Inc. | 46.8M | +0.1% | 2.4M | NNM | |
| PALI Palisade Bio, Inc. | 30.9M | -7.5% | 1.6M | SC | |
| SLDB Solid Biosciences Inc. | 16.4M | -1.4% | 866,303 | NNM | |
| GPGI GPGI, Inc. Class A | 28.7M | -6.5% | 1.5M | NYSE | |
| LENZ LENZ Therapeutics, Inc. | 10.9M | -2.9% | 575,660 | NNM | |
| SBH Sally Beauty Holdings, Inc. (Name to be changed from Sally Holdings… | 20.2M | +1.2% | 1.1M | NYSE | |
| XMAX XMAX, Inc. Common Stock | 9.3M | -11.7% | 498,209 | SC | |
| DMRC Digimarc Corporation | 2.3M | +9.3% | 123,703 | NNM | |
| LOVE The Lovesac Company | 3.0M | +7.2% | 161,720 | NNM | |
| HRTX Heron Therapeutics, Inc. | 44.9M | -4.0% | 2.4M | SC | |
| OLMA Olema Pharmaceuticals, Inc. | 15.7M | -0.9% | 845,052 | NNM | |
| GHRS GH Research PLC | 3.1M | -2.0% | 166,574 | NNM | |
| PRCH Porch Group, Inc. | 16.9M | -2.4% | 916,612 | SC | |
| EPRX Eupraxia Pharmaceuticals Inc. | 7.1M | +12.2% | 385,471 | SC | |
| KOD Kodiak Sciences Inc | 10.8M | +4.6% | 584,274 | NNM | |
| RC Ready Capital Corporation | 19.4M | +5.9% | 1.1M | NYSE | |
| LUCK Lucky Strike Entertainment Cor | 2.0M | +3.4% | 110,246 | NYSE | |
| OPAL OPAL Fuels Inc. Class A Common | 2.6M | +1.0% | 139,291 | SC | |
| CTSO Cytosorbents Corporation Commo | 2.3M | +6.9% | 126,008 | SC | |
| LOGI Logitech International S.A. - Registered Shares | 13.2M | +11.3% | 723,456 | NNM | |
| CXT Crane NXT, Co. | 8.0M | +10.7% | 438,093 | NYSE | |
| CRDF Cardiff Oncology, Inc. | 11.7M | -1.8% | 643,454 | SC | |
| LKFN Lakeland Financial Corporation | 2.4M | +3.5% | 130,063 | NNM | |
| DCOM Dime Commercial Bancshares, Inc. | 3.9M | +11.9% | 214,921 | NYSE | |
| SLP Simulations Plus, Inc. | 2.8M | +0.7% | 159,425 | NNM | |
| FRMM Forum Markets, Incorporated Co | 2.2M | -4.8% | 125,483 | SC | |
| RLMD Relmada Therapeutics, Inc. | 13.6M | +5.5% | 768,191 | SC | |
| PROK ProKidney Corp. - Class A Ordinary Shares | 20.7M | -3.5% | 1.2M | SC | |
| GIB CGI Inc. | 5.5M | -13.5% | 312,854 | NYSE | |
| DNLI Denali Therapeutics Inc. | 16.6M | -7.3% | 951,216 | NNM | |
| DERM Journey Medical Corporation | 3.0M | +1.5% | 169,699 | SC | |
| SKIN SkinHealth Systems Inc. Class | 7.2M | +1.8% | 412,811 | SC | |
| CMPX Compass Therapeutics, Inc. | 40.8M | +1.5% | 2.4M | SC | |
| MGNX MacroGenics, Inc. | 7.1M | -1.8% | 413,111 | NNM | |
| GEL Genesis Energy, L.P. Common Units | 2.7M | -12.8% | 156,018 | NYSE | |
| XPOF Xponential Fitness, Inc. Class A | 9.2M | +3.1% | 536,657 | NYSE | |
| GIII G-III Apparel Group, LTD. | 7.7M | +1.1% | 447,237 | NNM | |
| EMA Emera Incorporated | 5.6M | +3.4% | 325,492 | NYSE | |
| PBA Pembina Pipeline Corp. Ordinary Shares (Canada) | 14.2M | +5.5% | 833,636 | NYSE | |
| PCRX Pacira BioSciences, Inc. | 7.3M | +0.4% | 432,362 | NNM | |
| PCT PureCycle Technologies, Inc. | 55.5M | -0.2% | 3.3M | SC | |
| HASI HA Sustainable Infrastructure Capital, Inc. | 13.9M | +8.3% | 827,082 | NYSE |
Showing 100 exchange-listed securities with at least 1 million shares short and 100 thousand shares of average daily volume. 13,006 exchange-listed securities reported a position on this settlement date, totalling 45.2 billion shares. OTC issues are reported too and are excluded here.
What days to cover actually measures
Days to cover is the short position divided by the security's average daily trading volume. It answers one question: if every short seller decided to buy back at once, and they were the only buyers, how many full trading days would that take?
That framing is the whole point. A position of ten million shares means nothing by itself — it is enormous in a security that trades two hundred thousand shares a day and trivial in one that trades forty million. The ratio is what makes two securities comparable.
It is also the mechanism behind a squeeze, which is why the metric gets attention. When the number is large, the shorts cannot exit without being the dominant buyer for days on end, and their own buying pushes the price against them. When it is one or two, they can be out by lunchtime and nothing is crowded about the position.
Three measurements, one word
“Short” gets used for three datasets that do not measure the same thing, and reading one as another produces confident nonsense.
- Short interest — this page. A balance: shares borrowed, sold, and not yet bought back, as of a settlement date. Reported twice a month.
- Short volume — a flow. Trades flagged short on the day they execute. Most of it is a market maker shorting to fill your buy order and flattening minutes later, which is why the market-wide median sits near half and means nothing.
- Fails to deliver — a settlement break. Shares that did not arrive on time. Overwhelmingly operational, and explicitly not evidence of naked shorting.
A security can be high on one and low on the others. Reading them together is the only way any of them is informative.
Why this page does not show percent of float
Percent of float is the number most sites lead with, and it is the number we cannot honestly print. Float — shares actually available to trade, after insiders and restricted holdings — is not in any filing. Every float figure in circulation is a commercial vendor's estimate, they disagree with each other by material amounts, and they are licensed. Publishing one here would mean republishing a vendor's proprietary estimate as though it were the regulatory filing it sits next to.
Days to cover uses FINRA's own average-volume figure from the same file, so every number on this page comes from the one source.
Limits worth stating
- It lags. Positions are as of a settlement date roughly a week before publication, and the file arrives twice a month. In a fast-moving name the real position has already changed.
- Volume is FINRA's, not the consolidated tape. For a security whose trading is mostly on a foreign primary listing, the US average volume understates reality and days to cover comes out far too high. Several perennial members of this list are exactly that case rather than crowded shorts.
- A position is not a view. A large short can be one leg of a convertible-arbitrage or merger-arbitrage trade, or an index hedge, with no directional opinion attached at all.
- Zero-volume securities are dropped. FINRA writes a sentinel value where average volume is zero; it is stored as no value rather than as an enormous days-to-cover figure.
Where this comes from
FINRA publishes a consolidated short interest file twice a month, free and public, covering every equity security its members report. It is parsed here directly. Each security's own page pulls this together with its filings, ownership and settlement fails — see any ticker under security pages, or the rest of the Markets section.